FDA Inspection
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyBristol-Myers Squibb Holdings Pharma Ltd. Liability Company – FDA Inspection, Nov 19, 2019
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, with an inspection on November 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 19, 2019
- Product Type
- Drugs
View Company Profile
ID · 95d01da7-6768-4d14-9aa2-0bc74e7edaf0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110480
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
13| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | San Juan District Office | |
| June 6, 2024 | Not classified | San Juan District Office | |
| July 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.